Search hospitals > Illinois > Peoria
OSF Saint Francis Radiation Oncology at Peoria Cancer Center
Claim this profilePeoria, Illinois 61615
Global Leader in Parotid Gland Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Cervical Adenocarcinoma
Conducts research for Relapse
167 reported clinical trials
2 medical researchers
Summary
OSF Saint Francis Radiation Oncology at Peoria Cancer Center is a medical facility located in Peoria, Illinois. This center is recognized for care of Parotid Gland Cancer, Lung Cancer, Breast Cancer, Cervical Adenocarcinoma, Relapse and other specialties. OSF Saint Francis Radiation Oncology at Peoria Cancer Center is involved with conducting 167 clinical trials across 342 conditions. There are 2 research doctors associated with this hospital, such as Bryan A. Faller and James L. Wade.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage II
Stage I
Stage III
Top PIs
Bryan A. FallerCrossroads Cancer Center6 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Lung Cancer
239 reported clinical trials
296 drugs studied
James L. WadeDecatur Memorial Hospital4 years of reported clinical research
Studies Relapse
Studies Breast Cancer
11 reported clinical trials
20 drugs studied
Clinical Trials running at OSF Saint Francis Radiation Oncology at Peoria Cancer Center
Breast Cancer
Lung Cancer
Parotid Gland Cancer
Testicular cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Non-Small Cell Lung Cancer
Esophageal Adenocarcinoma
Cancer
Breast cancer
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at OSF Saint Francis Radiation Oncology at Peoria Cancer Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.